|
2025
|
Invention
|
Cancer vaccines and methods of treatment using the same.
The invention provides a vaccine compri... |
|
|
Invention
|
Vaccines having an antigen and interleukin-21 as an adjuvant.
Disclosed herein is a vaccine comp... |
|
|
Invention
|
Cancer vaccines targeting muc16 and uses thereof.
Disclosed herein are nucleic acid molecules co... |
|
|
Invention
|
Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of... |
|
2024
|
Invention
|
Vaccines against coronavirus and methods of use.
Disclosed herein are nucleic acid molecules enc... |
|
|
Invention
|
Cancer vaccines targeting boris and uses thereof.
Disclosed herein are nucleic acid molecules co... |
|
|
P/S
|
Pharmaceutical preparations for use in the treatment of recurrent respiratory papillomatosis (RRP... |
|
|
Invention
|
Intradermal jet injection electroporation.
A jet injection and electroporation device for use wi... |
|
|
Invention
|
Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines ma... |
|
|
Invention
|
Optimized nucleic acid antibody constructs.
Disclosed herein are compositions comprising structu... |
|
|
Invention
|
Cancer vaccines targeting survivin and uses thereof.
Disclosed herein are nucleic acid molecules... |
|
|
Invention
|
Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses compris... |
|
|
Invention
|
Dna antibody constructs for use against middle east respiratory syndrome coronavirus.
Disclosed ... |
|
|
Invention
|
Kinetic vacuum treatment devices, systems, and methods.
A method of enhancing delivery of an age... |
|
|
Invention
|
Kinetic vacuum treatment devices, systems, and methods. A method of enhancing delivery of an agen... |
|
|
Invention
|
Cancer vaccines targeting mesothelin and uses thereof.
Disclosed herein are nucleic acid molecul... |
|
|
Invention
|
Methods of treatment of high-grade squamous intraepithelial lesion (hsil). Described are methods ... |
|
|
Invention
|
Methods of treatment of high-grade squamous intraepithelial lesion (hsil).
Described are methods... |
|
|
Invention
|
Dna monoclonal antibodies targeting checkpoint molecules.
Disclosed herein is a composition incl... |
|
2023
|
Invention
|
Optimized synthetic consensus immunogenic compositions targeting the follicle stimulating hormone... |
|
|
Invention
|
Dna antibody constructs for use against hiv.
Disclosed herein is a composition including a recom... |
|
|
Invention
|
Dna monoclonal antibodies targeting influenza virus.
Disclosed herein is a composition including... |
|
|
Invention
|
Vaccines for human papilloma virus and methods for using the same.
Improved anti-HPV immunogens ... |
|
|
Invention
|
Lassa virus vaccine and uses thereof.
Described are methods of inducing a protective immune resp... |
|
|
Invention
|
Vacuum-assisted agent delivery devices, and related systems and methods.
A device for vacuum-ass... |
|
|
Invention
|
Lassa virus vaccine and uses thereof. Described are methods of inducing a protective immune respo... |
|
|
Invention
|
Vaccines for recurrent respiratory papillomatosis and methods of using the same.
Provided herein... |
|
|
Invention
|
Vaccines for recurrent respiratory papillomatosis and methods of using the same. Provided herein ... |
|
|
Invention
|
Combination of novel vaccines against zika virus and dna antibody constructs for use against zika... |
|
|
Invention
|
Mers-cov vaccine.
Disclosed herein is a vaccine comprising a Middle East Respiratory Syndrome co... |
|
|
Invention
|
Vacuum-assisted treatment device, and related systems and methods. Techniques for treating subjec... |
|
|
Invention
|
Vacuum-assisted treatment device, and related systems and methods.
Techniques for treating subje... |
|
|
Invention
|
Electroporation device with detachable needle array with lock-out system.
An electroporation dev... |
|
|
Invention
|
Intradermal injection device.
Embodiments herein relate to the field of injections, for instance... |
|
|
Invention
|
Method and device for minimally invasive in vivo transfection of adipose tissue using electropora... |
|
|
Invention
|
Immunogenic compositions against sars-cov-2 variants and their methods of use.
Disclosed herein ... |
|
|
Invention
|
Methods of treatment of high grade squamous intraepithelial lesion (hsil).
Described are methods... |
|
|
Invention
|
Immunogenic compositions against sars-cov-2 variants and their methods of use. Disclosed herein a... |
|
|
Invention
|
Handheld electroporation devices, and related systems and methods.
A method for preparing an ele... |
|
|
Invention
|
Handheld electroporation devices, and related systems and methods. A method for preparing an elec... |
|
|
P/S
|
scientific testing and analysis of cGMP processes in the field of nucleic acids including DNA pla... |
|
2022
|
Invention
|
Compositions and methods for treating anal high-grade squamous intraepithelial lesion (hsil).
Th... |
|
|
Invention
|
Compositions and methods for treating anal high-grade squamous intraepithelial lesion (hsil). The... |
|
|
P/S
|
Pharmaceutical preparations comprising nucleic acid encoded monoclonal antibody proteins produced... |
|
|
Invention
|
A tolerable and minimally invasive skin electroporation device.
A novel electroporation device f... |
|
2021
|
P/S
|
Vaccine preparations; Vaccines; Pharmaceuticals, namely, pharmaceutical products, preparations an... |
|
|
Invention
|
Compositions and methods for treating vulvar dysplasia.
The use of anti-HPV immunogens and nucle... |
|
2020
|
Invention
|
Hand-held electroporation device |
|
2018
|
P/S
|
Pharmaceutical compositions for the prevention and treatment of acquired immunodeficiency syndrom... |
|
2017
|
P/S
|
Pharmaceutical preparations for human use for the treatment and prevention of cancer and infectio... |
|
2015
|
P/S
|
Nucleic acid sequences and chemical reagents for medical and veterinary purposes; vaccine prepara... |
|
|
P/S
|
Medical apparatus for delivering nucleic acid molecules, pharmaceutical drugs or vaccines via ele... |
|
|
P/S
|
Pharmaceutical preparations and vaccines for the treatment of cancer and infectious diseases; Vac... |
|
2014
|
P/S
|
Chemicals for use in industry and science; chemicals and chemical preparations for use in the man... |
|
2008
|
P/S
|
Custom manufacture of nucleic acids including DNA plasmids, and current good manufacturing practi... |
|
2007
|
P/S
|
Nucleic acid sequences and chemical reagents for medical and veterinary purposes, specifically ex... |
|
|
P/S
|
Medical apparatus for delivering nucleic acid molecules, for example plasmids, or vaccines to mam... |
|
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment or prevention of infec... |
|
2005
|
P/S
|
Pharmaceuticals for treatment of cancer and for vaccination; none of the foregoing being for phar... |
|
|
P/S
|
Medical apparatus for use in delivering drugs or genes to cellular structures by means of electro... |
|
1997
|
P/S
|
Gene-based pharmaceutical products, useful to elicit an immune response to selected antigens. |
|
|
P/S
|
Pharmaceutical compositions of modified steroid hormone receptors. |
|
|
P/S
|
Surgical and medical apparatus and instruments and parts and fittings therefor. |
